HanAll Biopharma said it has made a strategic investment in Interon Laboratories, a Boston-based startup developing new drug candidates for treating Autism Spectrum Disorder (ASD).Based on the investment, HanAll Biopharma plans to seek opportunities to discover new materials and jointly develop new
Many things are returning to pre-Covid-19 days after lifting the indoor mask mandate, but one area fails to recover its previous vigor – HIV (human immunodeficiency virus) tests at public health centers.According to a report by the Korea Disease Control and Prevention Agency (KDCA) in 2021, 443,609
Dx&Vx, a Korean molecular diagnostics company, said it achieved record-high sales and successfully turned to an operating profit in 2022.According to the company's public filing on Friday, the company recorded sales of 32.2 billion won ($26.2 million) last year, up 331 percent compared to 2021.The c
Concerns are mounting that the finance ministry’s decision to downsize and relocate the National Medical Center (NMC) will make it difficult for the institution to play the role of the central hospital in dealing with infectious diseases.At a public debate organized by Rep. Cho Myung-hee of the Peop
The lowest court ruled in favor of Medytox in a civil lawsuit involving Medytox and Daewoong Pharmaceutical regarding the source of the latter's botulinum toxin (BTX) strain. The Seoul Central District Court on Friday ruled in favor of Medytox in the lawsuit filed by Medytox against Daewoong Pharmac
Cancer has taken off its label of “incurable” thanks to technological development but remains a serious disease that is hard to treat. As a result, patients and their families are particularly thirsty for information about whether they get the treatment they need on time and what kind of care they s
Hyundai Pharmaceutical said on Friday that it signed a new drug development agreement with C-NOPS Design, a new drug-candidate material design company based on computer-aided design and drawing (CADD).C-NOPS Design is a molecular design contract research organization (CRO) based on “Medichem Plus Si
Researchers in Korea have conducted a study that showed that regular exercise in type 2 diabetic patients reduces the risk of atrial fibrillation (AF), a type of arrhythmia that is the main cause of sudden death.Atrial fibrillation (AF) is a type of arrhythmia that causes rapid and irregular pulses
Insurance benefits for Hemlibra (emicizumab), a hemophilia A treatment supplied by JW Pharmaceutical, will likely be expanded to non-antibody patients, helping to ease their financial burden.The Health Insurance Review and Assessment Service (HIRA) held a drug benefit evaluation committee on Thursda
Merz Aesthetics is enhancing a competitive edge in the botulinum toxin (BTX) market after the approval of its BTX brand Xeomin for storage at room temperature.Merz held a press conference on Thursday celebrating the Ministry of Food and Drug Safety's approval of Xeomin as the only BTX product in Kor
Nu Eyne, a Korean healthcare start-up, was recently selected by the Ministry of Health and Welfare (MOHW) to develop bioelectronic medicine technology for the first Health and Medical Technology R&D project. The start-up began in 2017 with just four founding members but has since grown, with an on-s
Hugel said it posted record-high sales and operating profit in 2022 on the back of strong global sales of Botulax, its botulinum toxin product, and the Chaeum, its hyaluronic acid (HA) filler.According to the company’s public filing of the preliminary 2022 earnings on Wednesday, Hugel’s revenue reac
GC Cell said its annual sales and operating profit increased rapidly in 2022 thanks to its specimen collection and test business.According to the company's public filing on Thursday, the company recorded sales and operating profits of 236.1 billion won and 44.3 billion won ($187.2 million and $35.1
Even young women have an increased risk of diabetes if they have non-alcoholic fatty liver, researchers said Thursday.A trio at Kangbuk Samsung Hospital released the result of their study, which tracked 245,504 non-diabetic adults who received medical checks at their hospital from 2011 to 2018 for t
Lunit said it agreed with Agfa HealthCare, a multinational imaging company headquartered in Belgium, to supply an AI image analysis solution for breast cancer diagnosis to the Dubai Academic Health Corporation (DAHC) in the United Arab Emirates (UAE).The two companies have been collaborating to deve
A former intern at Asan Medical Center (AMC) was sentenced to one year and a half in prison on Thursday for sexually harassing a patient under anesthesia during surgery in 2019. It was the first trial and the intern was arrested immediately after the ruling. The Seoul Eastern District Court sentence
Due to the increase in the elderly population, the number of osteoporosis patients, most of whom are women aged 60 and older, is also steadily rising. Annual medical expenses for osteoporosis treatment have exceeded 300 billion won ($237 million) in 2021.The National Health Insurance Service (NHIS)
SK Biopharmaceuticals returned to an operating loss in 2022, a mere year after turning profitable in 2021.According to the company's public filing on Thursday, the company recorded an operating loss of 131.1 billion won ($103.6 million) on a consolidated basis in 2022, turning to a loss after report
Hanmi Pharmaceutical said it posted 1.33 trillion won in revenue in 2022, the largest ever in the company’s history, thanks to the sales growth of self-developed drugs including the dyslipidemia combo. According to the company’s public filing of the preliminary 2022 earnings on Wednesday, Hanmi’s re
Takeda's hereditary angioedema (HAE) treatment Takhzyro (lanadelumab) has expanded its indication to children aged two and older in the United States. However, few know when the drug will be released in Korea, although two years have passed since it won approval.Takeda said the U.S. FDA approved the